Regulatory Approach of Biosimilars

Competitions and/or success in the present pharma industry is determined by the winning patent strategy which mostly pertain to the generic market entry. Generic and branded drug manufacturers both the patent strategy proximally belongs to the Hatch-Waxman Act statutory scheme and ANDA litigations. The Hatch-Waxman Act enacted in 1984 with amendment in 2003 facilitated the entry of generics at an early stage-thereby finishing the battle of branded generic ANDA of blockbuster drugs. All the same the Biologics Price Competition and Innovation (BPCI) Act has maximized the branded-generic patent duel in the biologics realm by imposing a litigated framework on follow-on-biologics. On September 16, 2011 President Obama signed the American Invents Act(AIA) of 2011 indicating a further strategy evolution of patenting branded and generics.

An FDA analysis of drug prices from 1999 to 2004 found that the discount from generic competition was just 6% with one generic competitor, but jumps to 48% with two generic competitors, 56% with three, 61% with four and 67% with five generic producers in a market. Within 2 years of the expiration of the patent of the popular drug Zantac in 1997, generics of Zantac accounted 90% of the treatment’s total sales, and the price for patients was about 10% of its pre-generic price. European patents on biologic treatments began to expire in 2000, and in April 2006, Sandoz and Biopartners successfully received EMEA approval for the first European biogenerics, two products containing human growth hormone.

  • Licensing of biosimilars
  • BLA filing for biosimilars
  • Regulatory prospects of BRIC countries
  • Biowaiver approval for biosimilars

Related Conference of Regulatory Approach of Biosimilars

August 28-29, 2018

10th World Congress on Neuropharmacology

Paris, France
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic | Panorama Hotel Prague | Milevská 7, 140 63 Praha
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic | Panorama Hotel Prague | Milevská 7, 140 63 Praha
September 24-25, 2018

Middle East Pharmacy and Pharmaceutical Conference

Abu Dhabi, UAE
September 24-26, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 26-27, 2018

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-07, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 08-09, 2018

17th World Congress on Drug Formulation & Drug Delivery

Auckland, New Zealand
November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
November 16-17, 2018

5th Annual Congress on Clinical & Hospital Pharmacy

Tokyo, Japan
February 28-March 01, 2019

Global Pharmaceutical & Pharma Industry Conference

Osaka, Japan
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
March 22-23, 2019

5th International Conference on Antibiotics

Chicago, Illinois, USA
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
May 15-17, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Hyatt Regency Osaka, Japan
May 20-21, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
September 11-13, 2019

8th International Conference on Clinical Trials

| Orlando, Florida, USA

Regulatory Approach of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in